Sodium Thiosulfate therapy for Calcific Uremic Arteriolopathy

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 7, 2013, Pages 1162-1170

  Nigwekar, Sagar U ^a,b   Brunelli, Steven M ^c,d   Meade, Debra ^e   Wang, Weiling ^e   Hymes, Jeffrey ^e   Lacson, Eduardo ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DAVITA CLINICAL RESEARCH   (United States)

^e FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM THIOSULFATE;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIFIC UREMIC ARTERIOLOPATHY; CALCINOSIS; DRUG SAFETY; FATIGUE; FEMALE; FOLLOW UP; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; QUESTIONNAIRE; SIDE EFFECT; SODIUM BLOOD LEVEL; TREATMENT OUTCOME;

EID: 84879835292     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09880912     Document Type: Article

References (38)

1. Wilmer WA, Magro CM: Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15: 172-186, 2002.
2. Hayden MR, Goldsmith D, Sowers JR, Khanna R: Calciphylaxis: Calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol 40: 443-451, 2008.
3. Nigwekar SU, Wolf M, Sterns RH, Hix JK: Calciphylaxis from nonuremic causes: A systematic review. Clin J AmSoc Nephrol 3: 1139-1143, 2008.
4. Nigwekar SU: An unusual case of nonhealing leg ulcer in a diabetic patient. South Med J 100: 851-852, 2007.
5. Budisavljevic MN, Cheek D, Ploth DW: Calciphylaxis in chronic renal failure. J Am Soc Nephrol 7: 978-982, 1996.
6. Angelis M, Wong LL, Myers SA, Wong LM: Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery 122: 1083-1089, discussion 1089-1090, 1997.
7. Bazari H, Jaff MR, Mannstadt M, Yan S: Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers. N Engl J Med 356: 1049-1057, 2007.
8. Fine A, Zacharias J: Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 61: 2210-2217, 2002.
9. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR: Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56: 569-579, 2007.
10. Brandenburg VM, Cozzolino M, Ketteler M: Calciphylaxis: A still unmet challenge. J Nephrol 24: 142-148, 2011.
11. Mohammed IA, Sekar V, Bubtana AJ, Mitra S, Hutchison AJ: Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'. Nephrol Dial Transplant 23: 387-389, 2008.
12. Russell R, Brookshire MA, Zekonis M, Moe SM: Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care. Clin Nephrol 58: 238-243, 2002.
13. Kakagia D, Kriki P, Thodis E, Roumeliotis A, Vargemezis V: Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors. J Cutan Med Surg 15: 121-124, 2011.
14. Gonzalez-Parra E, Martin-Cleary C, Martin J, Ortiz A: Calcific uremic arteriolopathy while on cinacalcet. J Postgrad Med 57: 51-52, 2011.
15. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108, 2004.
16. Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A: Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol 6: 1447-1455, 2011.
17. Ross EA: Evolution of treatment strategies for calciphylaxis. Am J Nephrol 34: 460-467, 2011.
18. Auriemma M, Carbone A, Di Liberato L, Cupaiolo A, Caponio C, De Simone C, Tulli A, Bonomini M, Amerio P: Treatment of cutaneous calciphylaxis with sodium thiosulfate: Two case reports and a review of the literature. Am J Clin Dermatol 12: 339-346, 2011.
19. Meissner M, Bauer R, Beier C, Betz C, Wolter M, Kaufmann R, Gille J: Sodiumthiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology 212: 373-376, 2006.
20. Musso CG, Enz P, Vidal F, Gelman R, Lizarraga A, Giuseppe LD, Kowalczuk A, Garfi L, Galimberti R, Algranati L: Use of sodium thiosulfate in the treatment of calciphylaxis. Saudi J Kidney Dis Transpl 20: 1065-1068, 2009.
21. Miceli S, Milio G, La Placa S, Di Raimondo D, Tuttolomondo A, Li Vecchi M, Licata G, Pinto A: Sodium thiosulfate not always resolves calciphylaxis: An ambiguous response. Ren Fail 33: 84-87, 2011.
22. Malabu UH, Manickam V, Kan G, Doherty SL, Sangla KS: Calcific uremic arteriolopathy on multimodal combination therapy: Still unmet goal. Int J Nephrol 2012:390-768, 2012.
23. Selk N, Rodby RA: Unexpectedly severe metabolic acidosis associated with sodiumthiosulfate therapy in a patientwith calcific uremic arteriolopathy. Semin Dial 24: 85-88, 2011.
24. Schlieper G, Brandenburg V, Ketteler M, Floege J: Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5: 539-543, 2009.
25. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO: Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60: 324-332, 2001.
26. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23: 63-67, 1985.
27. Kyriakopoulos G, Kontogianni K: Sodiumthiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail 12: 213-219, 1990.
28. Papadakis JT, Patrikarea A, Digenis GE, Stamatelou K, Ntaountaki I, Athanasopoulos V, Tamvakis N: Sodium thiosulfate in the treatment of tumoral calcifications in a hemodialysis patient without hyperparathyroidism. Nephron 72: 308-312, 1996.
29. Sood AR, Wazny LD, Raymond CB, Leung K, Komenda P, Reslerova M, Verrelli M, Rigatto C, Sood MM: Sodium thiosulfatebased treatment in calcific uremic arteriolopathy: A consecutive case series. Clin Nephrol 75: 8-15, 2011.
30. Noureddine L, Landis M, Patel N, Moe SM: Efficacy of sodium thiosulfate for the treatment for calciphylaxis. Clin Nephrol 75: 485-490, 2011.
31. O'Neill WC, Hardcastle KI: The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant 27: 521-526, 2012.
32. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74: 1444-1453, 2008.
33. Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y; Japanese Calciphylaxis Study Group: A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27: 1580-1584, 2012.
34. Baldwin C, Farah M, Leung M, Taylor P, Werb R, Kiaii M, Levin A: Multi-intervention management of calciphylaxis: A report of 7 cases. Am J Kidney Dis 58: 988-991, 2011.
35. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-termintravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 18: 431-434, 2005.
36. Jones J: The effects of non-response on statistical inference. J Health Soc Policy 8: 49-62, 1996.
37. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR: Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis 48: 192-204, 2006.
38. Singh RP, Derendorf H, Ross EA: Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Clin J Am Soc Nephrol 6: 1155-1159, 2011